XRCC6 and pancreatic neoplasm: Recently, we revealed that CAFs derived from platinum-resistant patients can promote DNA damage repair by enhancing the interaction of the Ku70/Ku80 complex in pancreatic cancer cells through the secretion of IL-8, thereby inducing platinum resistance in pancreatic cancer [13].